Nutrition and Chemotherapy

• Conditions: Cancer

• Registration Number: NCT03840213
• Lead Sponsor: Institut de Cancérologie de la Loire

Brief Summary

Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even curative properties, with a specific indication for cancer patients treated by chemotherapy, is nowadays relayed by the media. To date, there are no studies conducted on the scope of this information in cancer patients or on the attitudes of oncologists towards this practice and possible positioning requests from patients.

We hypothesize that the choice of this practice and its modalities are rarely discussed with oncologists, although it may have deleterious repercussions on the patient's health.

We propose a research based on the principles of sociological intervention. Its objectives are a first review of the issue and the establishment of a joint working group, including patients, carers and researchers, which will propose solutions to improve the patient/carer dialogue on this issue.

Detailed Description

Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even curative properties, with a specific indication for cancer patients treated by chemotherapy, is nowadays relayed by the media. To date, there are no studies conducted on the scope of this information in cancer patients or on the attitudes of oncologists towards this practice and possible positioning requests from patients.

We hypothesize that the choice of this practice and its modalities are rarely discussed with oncologists, although it may have deleterious repercussions on the patient's health.

We propose a research based on the principles of sociological intervention. Its objectives are a first review of the issue and the establishment of a joint working group, including patients, carers and researchers, which will propose solutions to improve the patient/carer dialogue on this issue.

Study Timeline

• Status Verified: 2019-02
• Study First Submitted: 2019-02-11
• Study First Submitted QC: 2019-02-11
• Last Update Submitted: 2019-02-11
• Study First Posted: 2019-02-15
• Last Update Posted: 2019-02-15
• Study Start: 2019-02-20
• Primary Completion: 2019-12-31
• Study Completion: 2020-09-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Major patients, follow-up on Institut de Cancerology Lucien Neuwirth day service chemotherapy treatment
• Patient affiliated or entitled to a social security scheme
• Patient who received informed information about the study
• Patient able to read French

Patients participating in the qualitative study:

Exclusion Criteria

• Refusal to participate, protected adult person, under guardianship or curatorship
• Person unable to understand the conduct of the study
• Person with a documented history of cognitive or psychiatric disorders

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients who voluntarily changed their eating habits	1 year	Number of patients who voluntarily changed their eating habits will be reported

Secondary Outcome Measures

Name	Time	Method
Number of patients discussing these different practices with their oncologist	1 year	Number of patients discussing these different practices with their oncologist will be reported
Number of patients on therapeutic fasting or restrictive diet during chemotherapy treatment	1 year	Number of patients on therapeutic fasting or restrictive diet during chemotherapy treatment will be reported
Number of patients using complementary or alternative medicines	1 year	Number of patients using complementary or alternative medicines will be reported
Number of patients discussing these different practices with other caregivers	1 year	Number of patients discussing these different practices with other caregivers will be reported

Trial Locations

Locations (1)

Institut de Cancérologie Lucien Neuwirth; 🇫🇷 Saint-Priest-en-Jarez, France